Travere Therapeutics, Inc. · NASDAQ:TVTX
Rock Springs Capital Management LP's stake in Travere Therapeutics, Inc. fell to 3.30% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Rock Springs Capital Management LP's stake in Travere Therapeutics, Inc. fell to 3.30%, 2,921,196 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 3.30%
- Shares
- 2,921,196
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Rock Springs Capital Management LP | 3.30% | 2,921,196 |
| Rock Springs Capital LLC | 3.30% | 2,921,196 |
| Rock Springs Capital Master Fund LP | 2.60% | 2,327,521 |
| Mark Bussard | 3.30% | 2,921,196 |
| Kris Jenner | 3.30% | 2,921,196 |
Source
Related
- Travere Therapeutics, Inc.
- Rock Springs Capital Management LP
- Travere Therapeutics, Inc. shareholders
- Schedule 13G/A · Rock Springs Capital Management LP · Feb 14, 2025
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026